期刊文献+

丹参多酚酸盐对冠脉内支架置入术后细胞因子水平的影响 被引量:1

Effect of Salvianolate on Cytokins Level in Patients with Unstable Angina Pectoris after Stent Implantation.
下载PDF
导出
摘要 目的研究丹参多酚酸盐对不稳定型心绞痛(UAP)患者冠脉内支架置入后血清细胞因子水平的影响。方法将68例UAP患者随机分为常规治疗组及丹参多酚酸盐治疗组(丹参多酚酸盐组),观察支架置入前、支架置入后24h及1周血清白细胞介素18(IL-18),白细胞介素1(IL-1)以及可溶性细胞间黏附分子-1(sICAM-1)水平的变化,并与18例正常对照组比较。结果治疗前UAP患者血清IL-18、IL-1以及sICAM-1水平较正常对照组明显升高(均P<0.01),常规治疗组支架置入后24h较治疗前升高(P<0.05),治疗后1周较治疗前降低(P<0.05)。丹参多酚酸盐组支架置入后24h上述3种细胞因子水平较治疗前降低(P<0.05),治疗后1周降低更明显(P<0.01)。且丹参多酚酸盐组较常规治疗组下降明显(P<0.05)。结论 IL-18、IL-1和sICAM-1不同程度参与不稳定型心绞痛以及支架置入后冠状动脉管壁损伤的病理生理过程。丹参多酚酸盐可能通过调节上述细胞因子的表达,减轻冠脉局部的炎症级联反应,对UAP患者及支架置入后发挥较全面心血管保护作用。 Objective To investigate the serum level of cytokins and the effect of salvianolate in the patients with unstable angina pectoris (UAP) after stent implantation. Methods 68 patients undergoing stent implantation were divided randomly into conventional therapy group and salvianolate group. The level of Interleukin - 18( IL - 18 ), interleukin - 1 ( IL - 1 ) and intercellular adhesion molecular ( ICAM - 1 ) were evaluated by ELISA method before and 24h and 1 weeks after stent implantation. The level of IL - 18 ,L - 1 and ICAM - 1 were evaluated by ELISA, and the level of these cytokins were compared with 18 normal controls. Results The levels of serum IL - 18 ,IL - 1 and sICAM - 1 in patients with UAP were higher than those in the control group (P 〈0.01 ) and they were decreased 24 h after stent implantation in salvianolate group ( P 〈 0.05 ), while there was significant increase in conventional therapy group ( P 〈 0.05 ). The levels of the three cytokins were decreased both in conventional therapy group (P 〈0.05)and in salvianolate group (P 〈 0.01 ) lw after stent implantation, with more novel effect in the latter group ( P 〈 0.01 ). Conclusion It suggests that IL - 18, IL - 1 and sICAM - 1 may take part in the development of unstable angina pectoris and artery injury after stent implantation. Salvianolate may inhibit the inflammation in coronary artery by decreasing the secretion of IL- 18, IL- 1 and sICAM -1 ,thus play a protective role in patients with UAP after stent implantation.
出处 《医学研究杂志》 2010年第2期40-43,共4页 Journal of Medical Research
基金 中国人民解放军总后勤部"十一五"重点课题(2008CX125)
关键词 不稳定型心绞痛 支架置入术 丹参多酚酸盐 细胞因子 Unstable angina pectoris Stent implantation Salvianolate Cytokins
  • 相关文献

参考文献14

  • 1Packard RR, Libby P. Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin Chem, 2008, 54(1) :24 -38.
  • 2Kleemann R, Zadelaar S, Kooistra T. Cytokines and atherosclerosis: a comprehensive review of studies in mice. Cardiovasc Res, 2008,79 (3) :360 -376.
  • 3Blankenberg S, L uc G, Ducimet iere P,et al. Interleukin - 18 and the risk of coronary heart disease in European men : the prospecive epidemiological study of myocardial infarction ( PRIM E ) . Circulation, 2003, 108(20) :2453 -2459.
  • 4Apostolakis S, Vogiatzi K, Krambovitis E, et al. cytokines in cardiovascular disease: diagnostic, prognostic and therapeutic implications. Cardiovasc Hematol Agents Med Chem, 2008,6(2) :150-158.
  • 5Sattar N, Murray HM, Welsh P,et al. Are elevated circulating intercellular adhesion molecule 1 levels more strongly predictive of diabetes than vascular risk? Outcome of a prospective study in the elderly. Prospective Study of Pravastatin in Elderly at Risk Trial Study Group. Diabetologia, 2009,52 ( 2 ) :235 - 239.
  • 6苗阳,高铸烨,徐凤芹,汪晓芳,陈可远,张东.丹参多酚酸盐治疗冠心病心绞痛(心血瘀阻证)的临床观察[J].中药研究与信息,2005,7(10):23-26. 被引量:22
  • 7Souza JR, Oliveira RT, Blotta MH, et al. Serum levels of interleukin -6 ( I1 - 6 ), interleukin - 18 ( I1 - 18 ) and C - reactive protein (CRP) in patients with type - 2 diabetes and acute coronary syndrome without ST - segment elevation. Arq Bras Cardiol, 2008,90(2) :86 - 90.
  • 8Heiniseh RH, Zanetti CR, Comin F, et al. Serial changes in plasma levels of cytokines in patients with coronary artery disease. Vase Health Risk Manag. 2005,1 (3) :245 - 250.
  • 9Ozeren A, Aydin M, Tokac M, et al. Levels of serum IL - 1beta, IL - 2, IL - 8 and tumor necrosis factor - alpha in patients with unstable angina pectoris. Mediators Inflamm,2003,12(6) :361 -365.
  • 10Chamberlain J, Francis S, Brookes Z,et al. Interleukin- 1 regulates multiple atherogenic mechanisms in response to fat feeding. PLoS One, 2009, 231 (4) :5073 -5099.

二级参考文献40

共引文献117

同被引文献10

  • 1Tambe AA,Demany MA,Zimmerman HA,et al.Anginapectoris and slow flow velocity of dye in coronary arteries:a new angiographic finding[J].Am Heart J,1972,84(1):66-71.
  • 2Mangieri E,Macchiarelli G,Ciavolella M,et al.Slow coronary flow:clinical and histopathological features in patients with otherwise normal epicardial coronary arteries[J].Cathet Cardiovasc Diagn,1996,37 (4):375-381.
  • 3Fineschi M,Bravi A,Gori T.The slow coronary flow phenomenon:evidence of preserved coronary flow reserve despite increased resting microvascular resistances[J].Int J Cardiol,2008,127(3):358-361.
  • 4Mosseri M,Yarom R,Gotsman MS,et al.Histologic evidence for small vessel coronary artery disease in patients with anginapectoris and patent large coronary arteries[J].Circulation,1986,74:964-972.
  • 5Camsari A,Ozcan T,Ozer C,et al.Carotid artery in tima-media thickness correlates with intravascular ultrasound parameters in patients with slow coronary flow[J].Aherosclerosis,2008,200(2):310-314.
  • 6Turhan H,Saydam GS,Erbay AR,et al.Increased plasma soluble adhesion molecules;ICAM-1,VCAM -1,and E-select in levels in patients with slow coronary flow[J].Int J Cardiol,2006,108(2):224-230.
  • 7Gokce M,Kaplan S,Tekelioglu Y,et al.Platelet function disorder in patients with coronary slow flow[J].Clin Cardio,2005,28(3):145-148.
  • 8Sen N,Basar N,Maden O,et al.Increased mean platelet volume in patients with slow coronary flow[J].Platelets,2009,20(1):23-28.
  • 9李建军.冠状动脉慢血流综合征与炎症的关系[J].中国动脉硬化杂志,2009,17(1):1-3. 被引量:4
  • 10郭刚,徐峰,王冉,李耀民,于昕,刘向群.丹参多酚酸盐对非ST段抬高急性冠脉综合征患者炎症因子的影响[J].中国新药与临床杂志,2010,29(8):599-601. 被引量:5

引证文献1

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部